Method for detecting residual quantity of polycyclic aromatic hydrocarbon in traditional Chinese medicinal materials
The detection of 25 polycyclic aromatic hydrocarbons by gastric chromatography and specific chromatographic conditions was solved, and the evaluation problems of carcinogenic heavy aromatic hydrocarbons in Chinese medicinal materials were achieved, achieving high sensitivity and accuracy of polycyclic aromatic hydrocarbon analysis.
Patent Information
- Application Number
- CN202310540302.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2023-05-12
- Publication Date
- 2024-11-12
AI Technical Summary
The existing detection methods for polycyclic aromatic hydrocarbons of traditional Chinese medicinal materials are difficult to comprehensively evaluate heavy aromatics with stronger carcinogenicity, and the detection sensitivity and accuracy of complex medicinal materials are low, and there is a problem of matrix effect interference.
Gender chromatography, combined with AgilentDB-EUPAH column and triple quadrupole tandem mass spectrometer, detecting American and European foods through specific chromatographic and mass spectrometry conditions, including heating procedures, carrier gas, injection methods and mass spectrometry scanning mode. The 25 polycyclic aromatic hydrocarbons that are preferred by the Safety Administration, use analytical protective agents and matrix matching methods to reduce matrix interference.
It realizes high sensitivity and accurate detection of 25 polycyclic aromatic hydrocarbons in traditional Chinese herbal medicines, reduces matrix effect interference, and can comprehensively evaluate the risk of polycyclic aromatic hydrocarbon pollution in medicinal materials, with low detection limit and high quantification limit, suitable for traces of complex medicinal materials matrix. Quantity analysis.
Smart Images

Figure CN118937554A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of drug analysis and detection, and specifically relates to a method for detecting the residues of 25 polycyclic aromatic hydrocarbons in medicinal materials. Background Art
[0002] Polycyclic aromatic hydrocarbons (PAHs) are a class of compounds formed by two or more benzene rings. They are toxic, carcinogenic, and teratogenic. They are produced by the combustion or volatilization of fossil fuels and the combustion of biomass. Some PAHs are genotoxic, carcinogenic, or potentially carcinogenic.
[0003] Literature shows that the potential pollution pathways of PAHs in Chinese medicinal materials are mainly: first, absorption and enrichment from the environment; second, generation during high-temperature processing. On the one hand, medicinal materials directly absorb and enrich PAHs from the soil, air, and water sources in the growing environment; on the other hand, high-temperature processing may promote the transformation of PAHs, thereby increasing the amount of PAHs residues in medicinal materials and aggravating the PAH pollution of medicinal materials.
[0004] At present, there are few methods for detecting PAH residues in Chinese medicinal materials. Most of the PAHs involved in the detection are the 16 PAHs that are prioritized by the U.S. Environmental Protection Agency. However, there are few mentions of heavier aromatic hydrocarbons with stronger carcinogenicity mentioned in the European Food Safety Authority's priority monitoring list, such as dibenzo(a,h)anthracene, cyclopenta(c,d)pyrene, and 5-methyl-1,2-phenylene. This results in limitations in the safety risk assessment of Chinese medicinal materials caused by PAH contamination.
[0005] Secondly, the existing gas chromatography-mass spectrometry method for detecting PAHs mainly uses single ion detection scanning, which makes it difficult to achieve quantitative analysis for medicinal materials with complex background matrices.
[0006] In addition, in terms of sample pretreatment for PAHs detection and analysis, although the domestic pretreatment methods for food matrices are relatively mature, due to the large differences in matrix effects between medicinal materials and food, there is an urgent need to find a detection method for PAHs in complex medicinal material matrices. Summary of the invention
[0007] The purpose of the invention is to provide a detection method for 25 PAHs in complex medicinal material matrix samples. The method can detect the PAHs types that are prioritized by the U.S. Environmental Protection Agency and the European Food Safety Authority, so as to comprehensively assess the PAH contamination risk of Chinese medicinal materials. The method has the advantages of simple operation, high sensitivity and accuracy, and little matrix effect interference.
[0008] To achieve the above object, the present invention provides the following technical solutions:
[0009] A method for detecting the content of 25 kinds of polycyclic aromatic hydrocarbons in traditional Chinese medicine, wherein the names and structures of the 25 kinds of polycyclic aromatic hydrocarbons are shown in Table 1.
[0010] The detection method of the present invention adopts gas chromatography-mass spectrometry, and the method comprises:
[0011] 1. Preparation of test solution: Take Chinese medicinal materials and treat them with solvent to obtain test solution;
[0012] 2. Preparation of reference solution: Take 25 PAH standards and dissolve them in solvent to obtain reference solution;
[0013] 3. Determination: Inject the test solution and the reference solution into the gas chromatography-mass spectrometry (GC-MS) chromatograph to obtain a chromatogram. Calculate the contents of 25 PAHs in the test solution based on the chromatogram.
[0014] Wherein, the chromatographic conditions of the gas chromatography-mass spectrometry chromatograph are:
[0015] Agilent DB-EUPAH (20m×0.18mm×0.14μm) chromatographic column was used.
[0016] The carrier gas is high-purity helium (purity> 99%).
[0017] The injection port temperature was 250-350°C. Splitless injection was used.
[0018] Column flow rate 0.5-1.5 mL / min.
[0019] Injection volume 1-5μl.
[0020] Heating program: initially 75-85°C, hold for 1-3 minutes, increase the temperature by 5-10°C per minute to 240-260°C, hold for 1-3 minutes, then increase the temperature by 5-10°C per minute to 280-300°C, hold for 5-10 minutes, then increase the temperature by 15-25°C per minute to 310-350°C, hold for 15-20 minutes;
[0021] Mass spectrometry conditions: Detected by triple quadrupole tandem mass spectrometer; ion source is electron impact (EI) ion source, ion source temperature is 220-240°C. Collision gas is argon, flow rate is 0.5-1.5 mL / min. Mass spectrometry transmission interface temperature is 270-290°C.
[0022] The present invention can also include the preparation of blank solution, blank matrix solution, analytical protective agent solution, internal standard mixed reference solution and matrix mixed reference solution as needed. After these solutions are injected into the gas chromatography-mass spectrometry chromatograph as blanks and controls, they are beneficial to the correction of the chromatogram, improve the detection accuracy, and facilitate the accuracy of the calculation results.
[0023] Preferably, the detection method of the present invention comprises the following steps:
[0024] 1. Preparation of test solution:
[0025] Take 1-3g of the Chinese medicinal material, place it in a 40-60mL stoppered centrifuge tube, add 20-40ml of n-hexane, dichloromethane or a mixture thereof as a solvent, perform ultrasonic extraction 1-3 times, each ultrasonication for 10-30min, concentrate the obtained supernatant under reduced pressure in a 30-40°C water bath until 1-3ml of solvent remains, transfer it to a solid phase extraction column, rinse it with 3-9ml of n-hexane 1-3 times, and then elute it with 5-15ml of any one of dichloromethane, ethyl acetate or cyclohexane, collect the eluate, place it in a 30-40°C water bath and concentrate it under reduced pressure until 0.5-1.5ml of solvent remains, and make the volume to 2-3ml;
[0026] 2. Preparation of blank solution:
[0027] Preparation of blank solution: Take n-hexane and concentrate it, then transfer it to the Anpu MIP-PAHs purification column, elute it with n-hexane, and then elute it with dichloromethane. Collect all the eluent, concentrate it, and add dichloromethane to make up the volume;
[0028] If necessary, a blank matrix solution can also be used, and its preparation method is as follows: take 1-3 g of the blank matrix sample, place it in a 40-60 mL stoppered centrifuge tube, add 20-40 ml of n-hexane, dichloromethane or a mixture thereof as a solvent, perform ultrasonic extraction 1-3 times, each ultrasonication for 10-30 min, and concentrate the obtained supernatant under reduced pressure in a 30-40° C. water bath until 1-3 ml of solvent remains, transfer it to a solid phase extraction column, rinse it with 3-9 ml of n-hexane 1-3 times, and then elute it with 5-15 ml of any one of dichloromethane, ethyl acetate or cyclohexane, collect the eluate, place it in a 30-40° C. water bath and concentrate it under reduced pressure until 0.5-1.5 ml of solvent remains, and make it to 2-3 ml;
[0029] If necessary, an analytical protective agent solution may also be used, and the preparation method thereof is as follows: a ribonucleic acid lactone or a polyethylene glycol-triethylene glycol mixture is added to a solvent to prepare an analytical protective solution;
[0030] 3. Preparation of reference solution:
[0031] Preparation of reference solution: Take 25 PAH reference substances separately or mix them and add n-hexane to prepare reference solution;
[0032] If necessary, an internal standard mixed reference solution can also be used; its preparation method is as follows: take 0.5-2 ml of the deuterated mixed reference of 5 kinds of polycyclic aromatic hydrocarbons, put it in a 50-150 ml volumetric flask, add n-hexane to dilute it into 5-15 μg / ml internal standard mixed reference solution, shake well, and obtain.
[0033] If necessary, a matrix mixed reference substance solution may also be used, and the preparation method thereof is as follows: an appropriate amount of the mixed reference substance stock solution is measured, and a blank matrix solution is added to prepare a series of matrix mixed reference substance solutions;
[0034] 4. Determination method
[0035] 1-5 μl of the reference solution and the test solution were respectively injected into the gas chromatography tandem mass spectrometer for determination, and the contents of 25 PAHs in the test solution were calculated using the internal standard calibration curve method.
[0036] Wherein, the chromatographic conditions of the gas chromatography-mass spectrometry chromatograph are:
[0037] Agilent DB-EUPAH (20m×0.18mm×0.14μm) chromatographic column was used.
[0038] The carrier gas is high-purity helium (purity> 99%).
[0039] The injection port temperature was 250-350°C. Splitless injection was used.
[0040] Column flow rate 0.5-1.5mL / min.
[0041] Injection volume 1-5μl.
[0042] Heating program: initially 75-85°C, hold for 1-3 minutes, increase the temperature by 5-10°C per minute to 240-260°C, hold for 1-3 minutes, then increase the temperature by 5-10°C per minute to 280-300°C, hold for 5-10 minutes, then increase the temperature by 15-25°C per minute to 310-350°C, hold for 15-20 minutes;
[0043] Mass spectrometry conditions: Detected by triple quadrupole tandem mass spectrometer; ion source is electron impact (EI) ion source, ion source temperature is 220-240°C. Collision gas is argon, flow rate is 0.5-1.5 mL / min. Mass spectrometry transmission interface temperature is 270-290°C.
[0044] More preferably, the detection method of the present invention comprises the following steps:
[0045] 1. Preparation of test solution: Take Chinese herbal medicine, crush it into powder, take about 2g, weigh it accurately, put it in a 50mL stoppered centrifuge tube, add n-hexane, ultrasonically extract 3 times, 20ml for the first time, 10ml for the second and third times, ultrasonic for 30min each time, centrifuge at 3500r / min for 5min. Combine the supernatants, concentrate under reduced pressure in a 35℃ water bath until the solvent remains about 2ml, transfer to the Anpu MIP-PAHs purification column, wash the concentration bottle with 3ml of n-hexane once, transfer the washing liquid to the same Anpu MIP-PAHs purification column, rinse with n-hexane twice, 3ml each time, elute with 15ml of dichloromethane, collect all the eluents, place it in a 35℃ water bath and concentrate under reduced pressure until the solvent remains about 1ml, add dichloromethane to make it 2ml, vortex to mix, and pass through a 0.22μm organic filter membrane to obtain.
[0046] 2. Preparation of blank solution, blank matrix solution and analytical protective agent solution:
[0047] Preparation of blank solution: Measure 40 ml of n-hexane and place it in a rotary evaporator. Concentrate it under reduced pressure in a 35°C water bath until about 2 ml of solvent remains, transfer it to an Anpu MIP-PAHs purification column, wash the concentration bottle once with 3 ml of n-hexane, transfer the washing liquid to the same Anpu MIP-PAHs purification column, rinse it twice with n-hexane, 3 ml each time, elute with 15 ml of dichloromethane, collect all the eluate, place it in a 35°C water bath and concentrate it under reduced pressure until about 1 ml of solvent remains, add dichloromethane to make up to 2 ml, vortex to mix, and pass through a 0.22μm organic filter membrane to obtain.
[0048] Preparation of blank matrix solution: Take a blank matrix sample, crush it into powder (pass through a No. 4 sieve), take about 1g, accurately weigh, place in a 50mL stoppered centrifuge tube, add 40ml of n-hexane, and ultrasonically extract 3 times, 20ml for the first time, 10ml for the second and third times respectively, ultrasonically extract for 30min each time, and centrifuge (3500r / min) for 5min. The supernatants were combined, concentrated under reduced pressure in a 35°C water bath until about 2 ml of solvent remained, and transferred to an Anpu MIP-PAHs purification column (1 g / 10 ml, pre-washed with 5 ml of dichloromethane and 5 ml of n-hexane). The residue was washed once with 3 ml of n-hexane, and the washing liquid was transferred to the same Anpu MIP-PAHs purification column, and then rinsed twice with n-hexane, 3 ml each time, and then eluted with 15 ml of dichloromethane. All the eluates were collected, concentrated under reduced pressure in a 35°C water bath until about 1 ml of solvent remained, and dichloromethane was added to make up to 2 ml. The mixture was vortexed to mix well, and passed through a 0.22 μm organic filter membrane to obtain the product.
[0049] The analytical protective agent solution uses an acetone solution containing 1% polyethylene glycol and 2% triethylene glycol as the analytical protective agent solution; the preparation method is as follows: accurately measure 100 μl polyethylene glycol and 200 μl triethylene glycol, place them in a 10 ml volumetric flask, dilute to the scale with acetone, shake well, and obtain the analytical protective agent solution, which is stored in a -18°C refrigerator.
[0050] 3. Preparation of reference solution:
[0051] Preparation of reference stock solution: Take appropriate amount of 25 PAHs reference substances respectively, weigh accurately, add n-hexane to prepare reference stock solution. The specific concentration is shown in column C1 of the table below, and store in a -18℃ refrigerator.
[0052] Preparation of mixed reference substance stock solution: Take an appropriate amount of the above reference substance stock solution, add n-hexane to dilute it into a mixed reference substance stock solution. The specific concentration is shown in column C2 or C3 in the table below, and store it in a -18°C refrigerator.
[0053] Preparation of mixed reference solution: Take an appropriate amount of mixed reference stock solution and add n-hexane to prepare a mixed reference solution. The specific concentration is shown in column C4 or C5 in the table below.
[0054]
[0055]
[0056] Among them, C2 is the concentration of the mixed reference stock solution for licorice analysis, and C3 is the concentration of the mixed reference stock solution for Atractylodes macrocephala analysis. If the test sample is other Chinese medicinal materials, its concentration can be adjusted with reference to the concentrations of C2 and C3, such as adjusting the concentration range within 50% of the concentrations of C2 and C3, or adjusting within 25%, or adjusting within 10%.
[0057] Similarly, C4 is the concentration of the mixed reference solution for licorice analysis, and C5 is the concentration of the mixed reference solution for Atractylodes macrocephala analysis. If the test sample is other Chinese medicinal materials, its concentration can be adjusted with reference to the concentrations of C4 and C5, such as adjusting the concentration range within 50% of the concentrations of C4 and C5, or adjusting within 25%, or adjusting within 10%.
[0058] Preparation of internal standard mixed reference solution: Measure 1 ml of deuterated mixed reference of 5 kinds of polycyclic aromatic hydrocarbons (1000 μg / ml), place it in a 100 ml volumetric flask, add n-hexane to dilute it into 10 μg / ml internal standard mixed reference solution, shake well, and obtain.
[0059] Preparation of matrix mixed reference solution: Take an appropriate amount of mixed reference stock solution and add blank matrix solution to prepare a series of matrix mixed reference solutions;
[0060] 4. Determination method
[0061] Take 1 ml each of blank solution, blank solvent (dichloromethane), blank matrix solution, matrix mixed reference solution, mixed reference solution and test solution, add 20-50 μl analytical protectant solution and 50 μl internal standard mixed reference solution, mix well, take 1 μl of each of the above solutions and inject them into gas chromatography tandem mass spectrometer for determination, and calculate the contents of 25 PAHs in the test solution by the internal standard calibration curve method.
[0062] Chromatographic conditions: Agilent DB-EUPAH (20m×0.18mm×0.14μm) chromatographic column. Carrier gas is high-purity helium (purity>99%). Injection port temperature 300℃. Splitless injection. Column flow rate 1.0mL / min. Injection volume 1μl. Heating program: initial 80℃, hold for 2 minutes, increase to 250℃ at 10℃ per minute, hold for 2 minutes, then increase to 290℃ at 8℃ per minute, hold for 8 minutes, then increase to 320℃ at 20℃ per minute, hold for 16 minutes;
[0063] Mass spectrometry conditions: Detected by triple quadrupole tandem mass spectrometer; ion source was electron impact (EI) ion source, ion source temperature was 230°C. Collision gas was argon, flow rate was 1.0 mL / min. Mass spectrometry transmission interface temperature was 280°C.
[0064] In the present invention, the five internal standard compounds are five deuterated polycyclic aromatic hydrocarbon compounds, namely naphthalene-D8, acenaphthene-D10, phenanthrene-D10, chrysene-D12, and perylene-D12.
[0065] In the present invention, the blank matrix sample is a medicinal material of the same variety as the medicinal material to be tested and in which polycyclic aromatic hydrocarbons are not detected or the concentration of polycyclic aromatic hydrocarbons detected is low.
[0066] In the present invention, the Chinese medicinal material includes any Chinese medicinal material, such as any Chinese medicinal material in the Chinese Medicine Dictionary, preferably the following Chinese medicinal materials:
[0067] 1. Antipyretic drugs
[0068] Ephedra, cinnamon twig, perilla (perilla seed), angelica root, saposhnikovia root, angelica dahurica, asarum, ginger (ginger peel), magnolia, mint,
[0069] Burdock, mulberry leaf (mulberry bark, mulberry branch, mulberry), chrysanthemum, kudzu root, bupleurum, cicada shell, light black beans, vitex rotundifolia, (wood saint) willow.
[0070] 2. Heat-clearing drugs
[0071] Gypsum, Anemarrhena, Bamboo Leaf, Gardenia, Phragmites australis, Radix Rehmanniae, Scrophulariae, Cortex Moutan, Red Peony Root, Lithospermum officinale, Scutellaria baicalensis, Coptis chinensis, Phellodendron chinense, Dragon
[0072] Cnidium monnieri, Sophora flavescens, Dictamni bark, Honeysuckle (Honeysuckle vine), Forsythia suspensa, Taraxacum officinale, Smilax glabra, Houttuynia cordata, Red vine, Patrinia chinensis, Portulaca oleracea, Belamcanda chinensis, Sophora tonkinensis root, Prunella vulgaris (summer solstice grass, not in summer), Cassia seed, Buddleja mongholicus, Herba Polygoni Multiflori, Cortex Lycii, Bupleurum chinense, Artemisia annua.
[0073] 3. Expectorant
[0074] Pinellia, Arisaema, Radix Aconiti Lateralis, Sinapis alba, Radix Pseudostellariae, Inula, Peucedanum, Platycodon grandiflorum, Radix Trichosanthis, Rhizoma Chuanxiong
[0075] Fritillaria (Thai Fritillaria), Bamboo Shavings (fresh bamboo sap), Bamboo Phellodendron, Lepidium Officinale, Loquat Leaf, Realm, Aristolochia Seed, Kelp, Seaweed, Sterculia Lycopodiella, Bitter Almond (Sweet Almond), Aristolochia (Aristolochia), Stemona, Aster, Coltsfoot Flower, these two medicines are too expensive and not practical.
[0076] 4. Aromatic dehumidification
[0077] Patchouli, Cymbidium orientale, Atractylodes lancea, Acorus calamus (water calamus), Magnolia officinalis (Magnolia officinalis flower), Amomum villosum (Amomum villosum shell), White Cardamom (Cardamom shell), Amomum villosum (Cardamom fruit).
[0078] 5. Digestive Drugs
[0079] Chicken gizzard lining, hawthorn, malt, barley sprout, Shenqu, and radish seeds.
[0080] 6. Qi-regulating drugs
[0081] Citrus aurantium (Fructus aurantii), tangerine peel (tangerine peel, tangerine peel, tangerine leaf), costusroot (Euphrasia officinalis), persimmon calyx (persimmon frost), cyperus, green peel, bergamot
[0083] (Citron), Lindera strychnifolia, Aquilaria wood, Lychee kernel, Allium macrostemon, Sandalwood.
[0084] 7. Laxatives
[0085] Rhubarb, Glauber's salt, senna leaves, croton (heat-reducing), hemp seed, Prunus mume seed, honey, morning glory seed, euphorbia, Gelsemium elegans, Daphne dahurica, and Phytolacca americana.
[0087] 8. Antiparasitic Drugs
[0088] Quisqualis chinensis, chinaberry root bark (Toxialianzi), giant tangerine peel, pumpkin seed, thunder ball, torreya grandis, and crane lice.
[0089] 9. Drugs that open the mind
[0090] Bezoar, musk, borneol, styrax (benzoin), camphor.
[0091] 10. Warming Drugs
[0092] Aconite (Aconitum), dried ginger (Paojiang), cinnamon (Guan Gui), Evodia rutaecarpa, Zanthoxylum bungeanum (Zanthoxylum bungeanum), fennel, cloves, galangal, and Piper splendens.
[0093] 11. Flat dry quenching
[0094] Gastrodia elata, Gouteng, Bombyx batryticatus (silkworm excrement), earthworm, centipede, scorpion, antelope horn (goat horn), stone cassia, oyster, ochre, magnetite
[0095] Stone, white peony root, white Tribulus ternata, and Dogbane.
[0096] 12. Tranquilizing Drugs
[0097] Cinnabar, amber, pearl, dragon bone, wild jujube seed, cypress seed, polygala tenuifolia, and julibrissin bark (julibrissin flower, Celastrus orbiculatus).
[0098] 13. Promote diuresis and eliminate dampness
[0099] Poria, Polyporus, Alisma, Coix seeds, Lobelia, Corn silk, Wax gourd peel, Plantago seeds (Plantago), Akebia, Smilax glabra, Juncus effusus, Gastrodia elata, Lycopodiella cernua, Talc, Kochia scoparia, Artemisia capillaris, Moneywort, Polygonum cuspidatum.
[0100] 14. Anti-rheumatic drugs
[0101] Angelica dahurica, Gentiana macrophylla, Clematis chinensis, pine pollen, Smilax china, Pittosporum tobira bark, papaya, Streptococcus chinensis, Trachelospermum officinale, Caulis et Rhizoma Coptidis, Caulis et Rhizoma Cibotii, Geranium herb, Siegesbeckia sibiricum, Stinking Paulownia, Rhizoma Dioscoreae, Millennium Health, Luffa loofah, Rhizoma Smilacis Glabrae, Snakehead (Black-necked snake, snake skin), Strychnos nux vomica, Xanthium sibiricum, Bone-searching wind, Acanthopanax cortex, Acanthopanax northern bark, Cibotium bark, Viscum album, Drynaria fortunei, and Dipsacus asper.
[0102] 15. Hemostatic drugs
[0103] Agrimony (agrimony bud), Bletilla striata, palm charcoal, herb frost, cockscomb (cockscomb seeds), lotus node, small thistle, great cirsium, arborvitae leaves (Selaginella), sanguisorba officinalis, Imperata rhizome, Sophora japonica flower (Selaginella horn), Rheum officinale, ground ivy, Panax notoginseng, flower stone, pollen, blood charcoal, Sedum notoginseng, Agarwood, Mugwort, Fuluo liver (stove heart stone).
[0104] 16. Activate blood circulation and remove blood stasis
[0105] Chuanxiong, Salvia miltiorrhiza, Millettia reticulata, Leonurus japonicus (Cnidium monnieri), Zedoaria, Chinese rose, Achyranthes bidentata (Achyranthes bidentata), Curcuma aromatica, Turmeric, Corydalis yanhusuo (Rhizoma Corydalis), Frankincense, Myrrh, Atractylodes macrocephala, Sanguisorba officinalis, Copper monnieri, Sappan wood, Ilex tomentosa, Peach kernel, Safflower, Curcuma zedoaria, Trillium, Liujinu, Pangolin, Vaccaria segetalis, Gleditsia sinensis thorn, Leech, Lacquer, Campsis creeper.
[0106] 17. Tonic Medicine
[0107] Ginseng (ginseng stem, ginseng leaf), Codonopsis pilosula, Pseudostellaria pseudoginseng, Astragalus, Atractylodes macrocephala, yam, licorice, Schisandra chinensis, white hyacinth bean, jujube, maltose, deer antler (deer antler, deer antler glue, deer antler frost), Psoralea corylifolia, Morinda officinalis, Epimedium, Curculigo orchioides, Cistanche deserticola, Actinolite, Cuscuta australis, Astragalus membranaceus, Cornus officinalis, Eucommia ulmoides, Cnidium monnieri, Cordyceps sinensis, Gecko, Hippocampus, Cynomorium songaricum, walnut kernel, Fenugreek, Placenta, Rehmannia glutinosa, Polygonum multiflorum, Angelica sinensis, donkey-hide gelatin, wolfberry, longan meat, mulberry, Adenophora australis, Codonopsis pilosula, American ginseng, Ophiopogon japonicus, Asparagus cochinchinensis, Dendrobium candidum, Lilium, Polygonatum odoratum, Polygonatum sibiricum, Ligustrum lucidum, Dryopteris chinensis, turtle shell, tortoise shell, black sesame.
[0108] 18. Astringent Drugs
[0109] Ephedra root, floating wheat (wheat), red ochre, Yu Yuliang, nutmeg, terminalia chebula, poppy shell, black plum, pomegranate peel, gallstone, gallnut, Chinese toon bark (water hyacinth), golden cherry, mulberry silkworm cocoon, Alpinia oxyphylla, cuttlefish bone, ginkgo, Euryale ferox, lotus seeds (caesalpinia seeds, lotus seed heart, lotus stamens, lotus leaves, lotus stems, lotus pods), raspberries;
[0110] 19. Topical medications
[0111] Sulfur, realgar, mercury, calomel, arsenic, calamine, borax, realgar, alum, soap alum, white borax, cyperus rotundus, hibiscus bark, blister beetle, beehive, elephant skin (ivory), garcinia, wolfsbane.
[0112] 20. Anti-tumor drugs
[0113] Catharanthus roseus, camptotheca acuminata, cedarwood, aconite, trillium, oldenlandia diffusa, scutellaria barbata, gentiana scabra, licorice, scutellaria baicalensis, knotweed, snakeberry, dioscorea bulbifera, nightshade, skyranthes, radix pear trees, and cypress.
[0114] The method of the present invention is obtained through screening, and the screening process is as follows:
[0115] 1. Establishment of detection method
[0116] 1. Selection of chromatographic conditions
[0117] 1.1 Selection of chromatographic columns
[0118] According to the results of the reference search, based on the analytical conditions with similar determination indicators, the separation effects of 25 PAHs on Agilent DB-5MS (30m×0.25mm×0.25μm) and Agilent DB-EUPAH (20m×0.18mm×0.14μm) columns were investigated. The basic information of the 25 PAHs is shown in Table 1. The results showed that the separation of isomers BbFA, BjFA, and BkFA on the two columns was very different. On the DB-5MS column, BbFA and BjFA were completely combined into one chromatographic peak, while on the DB-EUPAH column, the separation degree of the two substances was 1.205. Considering that isomers cannot be distinguished in mass spectrometry, the DB-EUPAH column was selected as the gas chromatography column for this method (the separation of BbFA, BjFA, and BkFA on the two columns is shown in Figure 1 ).
[0119] Table 1 Basic information of 25 PAHs
[0120]
[0121] 1.2 Investigation of heating program
[0122] During the exploration of the temperature program, it was found that IP had a shoulder peak, which was speculated to be the fragment ion m / z276 of DBahA. The separation of IP and DBahA was improved by setting a 290℃ constant temperature platform at the peak time, so that the IP and DBahA fragment ion peaks were separated, and the separation of the two chromatographic peaks was 1.097, which could realize the integration operation of the IP chromatographic peak. The temperature program before adjustment was: initial temperature 80℃, maintained for 2min, heated to 250℃ at 10℃ / min, maintained for 2min, then heated to 315℃ at 8℃ / min, then heated to 320℃ at 2℃ / min, and maintained for 16min. According to the experimental results, the column temperature program was finally determined as follows: initial temperature 80°C, hold for 2 min, increase the temperature to 250°C at 10°C / min, hold for 2 min, then increase the temperature to 290°C at 8°C / min, hold for 8 min, then increase the temperature to 320°C at 20°C / min, hold for 16 min (see the chromatographic peak separation of IP and DBahA after adjusting the temperature program). Figure 2 ).
[0123] 1.3 Investigation of injection method
[0124] In order to improve the response of the chromatographic peak of the target compound and ensure the peak shape of each chromatographic peak, the peak shape and response differences of the target compound when the split liner and the splitless liner were selected in the splitless injection mode were investigated, and the effects of different split ratios on the peak shape and response of the target compound in the split injection mode were investigated. The results showed that there was no obvious difference in the peak shape of the target compound under the split and splitless injection modes, but the response of the target compound was higher when the splitless liner was used. In the split injection mode, the response of the target compound gradually decreased with the increase of the split ratio. Split injection will affect the LOD and LOQ values and the low-level value of the spiked recovery rate in the accuracy test. The peak area of the split injection substance is reduced, which will lead to an increase in the quantitation limit and detection limit of some substances that originally had a low response on the instrument. Therefore, the RSD can only be guaranteed by increasing the low-level value of the spiked recovery rate. Therefore, the splitless injection method was finally selected, and the splitless liner was used for sample detection and analysis. (For details on the results of the injection method and split ratio investigation, see Figure 3 ).
[0125] 1.4 Analysis of protective agents
[0126] Due to the presence of metal ion and silanol active sites in the gas chromatograph injection port and chromatographic column, sensitive analytes are adsorbed or degraded at the active sites, resulting in analyte loss or chromatographic peak tailing. An analytical protective agent is added to the standard solution so that the analytical protective agent replaces the matrix to occupy the active sites of the gas chromatograph, thereby improving the peak shape and response of the target compound in the solvent standard solution, thereby achieving the effect of matrix effect compensation. The present invention investigates the effects of two commonly used analytical protective agents (ribonucleolactone and polyethylene glycol-triethylene glycol) on the peak area and peak shape of each chromatographic peak. The results show that the addition of both analytical protective agents improves the tailing of the chromatographic peak shape and the separation, and the improvement effect is comparable. For details, see Figure 4-1 . However, ribonucleic acid lactone has a high polarity, and acetonitrile is generally required to be introduced during the preparation of the solution, which affects the long-term stability of the gas chromatograph system; at the same time, due to the influence of solubility, ribonucleic acid lactone is not suitable for the determination of target compounds in solvent systems with weaker polarity. Therefore, an acetone solution containing 1% PEG and 2% TEG was selected as an analytical protective agent. Then, the effect of 1% PEG and 2% TEG acetone solutions on the peak area of the target compound when the volume was 30μl, 40μl, and 50μl, respectively, was investigated. The results are detailed in Figure 4-2 It was found that there was no significant difference in the peak area of the target compound under different analytical protective agent volumes. It can be considered that the peak area of the target compound is not greatly affected by the analytical protective agent volume. Therefore, the volume of the analytical protective agent was selected to be 30 μl.
[0127] 2. Selection of mass spectrometry conditions
[0128] 2.1 Selection of scanning mode
[0129] The commonly used scanning modes for quantitative analysis of trace substances on GC-MS / MS are Single Ion Monitoring (SIM) and Multiple Reaction Monitoring (MRM). SIM is for the primary mass spectrometry, and only one ion is scanned. It is more suitable for matrices with fewer impurities and less interference. MRM is between two levels of the secondary mass spectrometry or multi-stage mass spectrometry, that is, one ion is selected for the parent ion, and after collision, only one ion is selected from the formed daughter ions. It has higher sensitivity and is suitable for samples with complex matrices. The peaks of the target compounds under the two scanning modes were compared. It was found that when using the SIM scanning mode, the chromatographic peaks of some target compounds were interfered by the matrix background and could not be accurately quantitatively analyzed. When using the MRM scanning mode, more noise and interference are eliminated, and the chromatographic peaks of the target compounds are less interfered by the background, which can meet the accurate quantitative requirements. Therefore, the MRM scanning mode is selected for sample quantitative analysis (for a detailed comparison of the chromatographic peaks of Nap-D8, Nap, Acy, AcP-d10, and Ace in the spiked samples of Atractylodes macrocephala under SIM and MRM scanning modes, see Figure 5 ).
[0130] 2.2 Collision energy optimization
[0131] The SCAN scanning method was used to identify the precursor ions of each substance, and the product ions were set in the product ion scanning mode and the collision energy CE value was automatically optimized, as shown in Table 2. The peaks of each substance were good, and the chromatographic peaks were relatively symmetrical. The total ion current chromatograms of 25 PAHs standard solutions and 5 internal standard solutions (50.0 μg / L) were measured by GC-MS. Figure 6 .
[0132] Table 2 GC-MS parameters of 25 PAHs and 5 internal standard compounds
[0133]
[0134]
[0135] 3. Selection of sample pretreatment method
[0136] 3.1 Selection of extraction solvent
[0137] Common PAHs extraction solvents include n-hexane, dichloromethane, acetone, acetonitrile or their mixtures. During the method development process, attempts were made to use n-hexane, dichloromethane, and n-hexane-dichloromethane (1:1, v:v) for extraction. The results showed that the overall recovery rate of 25 PAHs was the best when n-hexane was used as the extraction solvent. The addition of dichloromethane can appropriately increase the recovery rate of low-ring PAHs, but more impurities will be extracted at the same time, interfering with quantitative analysis. On the basis of ensuring the extraction effect, in order to minimize the interference of impurities, the extraction solvent was determined to be n-hexane. For detailed results, see Figure 7-1 .
[0138] 3.2 Selection of extraction solvent volume
[0139] The effects of 20ml, 30ml and 40ml of n-hexane extraction volume on the extraction of 25 PAHs were investigated. The results showed that the recovery rate of 2-3-ring PAHs increased with the increase of extraction solvent volume, while the recovery rate of 4-6-ring PAHs did not change significantly. In order to ensure the full extraction of low-ring aromatic hydrocarbons, the extraction solvent volume was determined to be 40ml. The detailed results are shown in Figure 7-2 .
[0140] 3.3 Selection of extraction time
[0141] The effects of ultrasonic time of 10min, 20min, and 30min on the recovery of target compounds were investigated. The results showed that with the extension of ultrasonic time, the recovery of 2-3-ring PAHs slowly increased, while there was no significant difference in the recovery of 4-6-ring PAHs. The overall recovery of target compounds in the test solution obtained by ultrasonication for 30min was the highest and close to 100% (Nap, Acy, Ace, and Flu are easily lost during the evaporation process due to their low molecular weight and low boiling point, resulting in a low recovery rate). In order to fully extract low-ring aromatic hydrocarbons, the ultrasonic time was determined to be 30min. For detailed results, see Figure 7-3 .
[0142] 3.4 Selection of extraction times
[0143] The effects of extraction times 1, 2, and 3 on the recovery of target compounds were investigated. The results showed that the overall recovery of target compounds gradually increased with the increase in the number of extractions. When the number of extractions was 3, the overall recovery of target compounds was the best and close to 100%. In order to fully extract PAHs, the number of extractions was determined to be 3. The detailed results are shown in Figure 7-4 .
[0144] 3.5 SPE column selection
[0145] According to the structural characteristics of PAHs, the retention of target compounds by fillers such as C18, mixed strong anion exchange adsorbent, polystyrene divinylbenzene, and MIP-PAH was investigated and evaluated by the sample recovery rates of 25 PAHs. Experiments have shown that when C18 filler is used for sample purification, the target compound will flow out with the loading solution eluent, and the retention effect on the SPE column is poor; the mixed strong anion exchange adsorbent has a poor effect on removing impurities in medicinal materials, and the chromatographic peak of the target compound cannot be qualitatively analyzed due to the interference of the matrix background; the polystyrene divinylbenzene filler has a poor retention effect on low-ring PAHs (Acy, Ace, Flu), with a recovery rate of less than 30%, and the recovery rates of the remaining 22 PAHs are between 69.73% and 139.57%; the SPE column with MIP-PAH as filler has the best retention of 25 PAHs, with a recovery rate of 78.02% to 137.10%, and the recovery rates of Flu, Phe, ANT, Flt, and Pyr are higher than 120%, which is due to the large amount of detection interference in the medicinal materials; therefore, the MIP-PAH column is considered suitable for the sample analysis of this experiment. A commercial MIP-PAH column (Anpu MIP-PAH column, 1 g, 10 ml) was selected for subsequent optimization of the elution volume and elution volume. The detailed results are shown in Figure 8-1 .
[0146] 3.6 Investigation of elution solvent volume
[0147] Due to the complexity of the matrix of traditional Chinese medicine, impurities have a great interference in the quantitative analysis of the target compound. In order to achieve accurate quantitative requirements, the effect of 3ml, 6ml, and 9ml of n-hexane elution on the recovery rate of the target compound was investigated. The results showed that the recovery rate of 2-4 ring PAHs decreased with the increase of elution volume. In order to remove impurities as much as possible while ensuring the recovery rate of the substance, the elution volume was determined to be 6ml. The detailed results are shown in Figure 8-2 .
[0148] 3.7 Investigation of elution solvent types
[0149] The effects of dichloromethane, ethyl acetate, and cyclohexane as elution solvents on the recovery of target compounds were investigated, and dichloromethane was the best elution solvent. The results showed that dichloromethane and ethyl acetate had similar elution abilities for 3, 4, and 5-ring aromatic hydrocarbons, but dichloromethane had better elution abilities for 2 and 6-ring aromatic hydrocarbons than ethyl acetate, and cyclohexane had no elution ability for 4 to 6-ring aromatic hydrocarbons. In order to maximize the overall recovery of 25 PAHs, dichloromethane was determined to be the elution solvent. The detailed results are shown in Figure 8-3 .
[0150] 3.8 Investigation of elution solvent volume
[0151] The effect of elution solvent volume of 5ml, 10ml and 15ml on the recovery rate of target compounds was investigated. The results showed that the overall recovery rate of 25 PAHs increased with the increase of elution volume. When the elution volume was 15ml, the overall recovery rate was optimal and close to 100%. In order to ensure that all target compounds were eluted, the elution solvent volume was determined to be 15ml. The detailed results are shown in Figure 8-4 .
[0152] 4. Determination Method
[0153] Based on the above analysis, the final determination method for 25 PAH residues in medicinal materials is as follows.
[0154] 4.1 Preparation of blank solution, blank matrix solution and analytical protective agent solution
[0155] Preparation of blank solution: Accurately measure 40 ml of n-hexane and place it in a rotary evaporator. Concentrate under reduced pressure in a 35°C water bath until about 2 ml of solvent remains, transfer to an Anpu MIP-PAHs purification column (1g / 10 ml, pre-washed with 5 ml of dichloromethane and 5 ml of n-hexane), wash the residue once with 3 ml of n-hexane, transfer the washing liquid to the same Anpu MIP-PAHs purification column, rinse twice with n-hexane, 3 ml each time, and then elute with 15 ml of dichloromethane, collect all the eluate, place it in a 35°C water bath and concentrate under reduced pressure until about 1 ml of solvent remains, add dichloromethane to make up to 2 ml, vortex to mix, and pass through a 0.22μm organic filter membrane to obtain.
[0156] Preparation of blank matrix solution: Take a blank matrix sample, crush it into powder (pass through a No. 4 sieve), take about 1g, accurately weigh, place in a 50mL stoppered centrifuge tube, add 40ml of n-hexane, and ultrasonically extract 3 times, 20ml for the first time, 10ml for the second and third times respectively, ultrasonically extract for 30min each time, and centrifuge (3500r / min) for 5min. The supernatants were combined, concentrated under reduced pressure in a 35°C water bath until about 2 ml of solvent remained, and transferred to an Anpu MIP-PAHs purification column (1 g / 10 ml, pre-washed with 5 ml of dichloromethane and 5 ml of n-hexane). The residue was washed once with 3 ml of n-hexane, and the washing liquid was transferred to the same Anpu MIP-PAHs purification column, and then rinsed twice with n-hexane, 3 ml each time, and then eluted with 15 ml of dichloromethane. All the eluates were collected, concentrated under reduced pressure in a 35°C water bath until about 1 ml of solvent remained, and dichloromethane was added to make up to 2 ml. The mixture was vortexed to mix well, and passed through a 0.22 μm organic filter membrane to obtain the product.
[0157] Preparation of analytical protective agent solution: Accurately measure 100 μl of polyethylene glycol and 200 μl of triethylene glycol, place in a 10 ml volumetric flask, dilute to the scale with acetone, shake well, and store in a -18°C refrigerator.
[0158] 4.2 Preparation of reference solution
[0159] Preparation of reference stock solution: Take appropriate amount of 25 PAHs reference substances respectively, weigh accurately, add n-hexane to prepare reference stock solution. The specific concentration C1 is shown in Table 3, and store in a -18℃ refrigerator.
[0160] Preparation of mixed reference stock solution: Accurately measure an appropriate amount of the above reference stock solution, add n-hexane to dilute it into a mixed reference stock solution. The specific concentrations are shown in Table 3 (C2 is the concentration of the mixed reference stock solution for licorice analysis, and C3 is the concentration of the mixed reference stock solution for Atractylodes macrocephala analysis), and store in a -18°C refrigerator.
[0161] Preparation of mixed reference solution: Accurately measure an appropriate amount of mixed reference stock solution and add n-hexane to prepare a mixed reference solution. The specific concentrations are shown in Table 3 (C4 is the concentration of the mixed reference solution for licorice analysis, and C5 is the concentration of the mixed reference solution for Atractylodes macrocephala analysis).
[0162] Preparation of internal standard mixed reference solution: Accurately measure 1 ml of 5 kinds of polycyclic aromatic hydrocarbon deuterated mixed reference (1000 μg / ml), place it in a 100 ml volumetric flask, add n-hexane to dilute it into 10 μg / ml internal standard mixed reference solution, shake well, and obtain.
[0163] Preparation of matrix mixed reference solution: Accurately measure an appropriate amount of the mixed reference stock solution and add blank matrix solution to prepare a series of matrix mixed reference solutions. The specific concentrations of the matrix mixed reference solutions for licorice analysis are shown in Table 4, and the specific concentrations of the matrix mixed reference solutions for Atractylodes analysis are shown in Table 5.
[0164] Table 3 Concentrations of 25 reference substance stock solutions and mixed reference substance stock solutions
[0165]
[0166] Table 4 Concentrations of 25 series of mixed reference solutions for licorice analysis (ng / ml)
[0167]
[0168] Table 5 Concentrations of 25 series of mixed reference solutions for Atractylodes macrocephala analysis (ng / ml)
[0169]
[0170]
[0171] 4.3 Preparation of test solution
[0172] Take the test sample, crush it into powder (pass through No. 4 sieve), take about 2g, weigh it accurately, put it in a 50mL stoppered centrifuge tube, add 40ml of n-hexane, and ultrasonically extract it 3 times, 20ml for the first time, 10ml for the second and third times respectively, ultrasonicate for 30min each time, and centrifuge (3500r / min) for 5min. The supernatants were combined, concentrated under reduced pressure in a 35°C water bath until about 2 ml of solvent remained, and transferred to an Anpu MIP-PAHs purification column (1 g / 10 ml, pre-washed with 5 ml of dichloromethane and 5 ml of n-hexane). The residue was washed once with 3 ml of n-hexane, and the washing liquid was transferred to the same Anpu MIP-PAHs purification column, and then rinsed twice with n-hexane, 3 ml each time, and then eluted with 15 ml of dichloromethane. All the eluates were collected, concentrated under reduced pressure in a 35°C water bath until about 1 ml of solvent remained, and dichloromethane was added to make up to 2 ml. The mixture was vortexed to mix well, and passed through a 0.22 μm organic filter membrane to obtain the product.
[0173] 4.4 Gas chromatography-mass spectrometry conditions
[0174] Agilent DB-EUPAH (20m×0.18mm×0.14μm) chromatographic column. Carrier gas is high-purity helium (purity>99%). Inlet temperature 300℃. Splitless injection. Column flow rate 1.0mL / min. Injection volume 1μl. Heating program: initial 80℃, hold for 2 minutes, increase to 250℃ at 10℃ per minute, hold for 2 minutes, then increase to 290℃ at 8℃ per minute, hold for 8 minutes, then increase to 320℃ at 20℃ per minute, hold for 16 minutes. Ion source temperature 230℃. Interface temperature 280℃. EI ionization mode. See Table 2 for the monitoring ion pairs and collision energies of 25 PAHs and internal standard references.
[0175] 4.5 Determination method
[0176] Take 1 ml of blank solution, blank solvent (dichloromethane), blank matrix solution, matrix mixed reference solution, mixed reference solution and test solution respectively, accurately add 30 μl analytical protective agent solution and 50 μl internal standard mixed reference solution, and mix well. Take 1 μl of the above solutions and inject them into gas chromatography tandem mass spectrometer for determination, and calculate the content by internal standard calibration curve method.
[0177] 2. Methodological Validation
[0178] In order to ensure the accuracy of the PAHs residue determination method in medicinal materials, a methodological validation was conducted to prove that the established method is accurate and reliable and can complete the detection of PAHs residues in medicinal materials. The specific contents are as follows.
[0179] 1. Methodological validation of PAHs detection and analysis methods in licorice herbs
[0180] 1.1. Exclusivity
[0181] Blank matrix solution: Take a licorice blank matrix sample and prepare a licorice blank matrix solution according to the blank matrix solution preparation method determined above.
[0182] The blank solution, blank solvent (dichloromethane), blank matrix solution, matrix mixed reference solution and mixed reference solution were analyzed and tested according to the GC-MS / MS conditions determined above. The test results are shown in Table 6. The example chromatogram is shown in Figure 9-1 .
[0183] The results showed that within the range of ±0.1min of the retention time of the target compound, there were no interfering peaks in the blank solvent (dichloromethane) and the blank solution, and the blank matrix solution was detected at the retention time position, which could be confirmed as positive by the ion ratio. Since PAHs were detected to varying degrees in the licorice samples, and the verification results of the ion ratio and retention time were good, false positive results could be effectively avoided by examining the retention time and three ion channels when actually testing the samples. It can be considered that the specificity of PAHs meets the requirements.
[0184] Table 6 Specificity and ion ratio test results of the analytical method for detecting PAHs in licorice herbs
[0185]
[0186]
[0187] 1.2 Ion ratio
[0188] The mixed reference solution and the matrix mixed reference solution were respectively analyzed and tested according to the GC-MS / MS conditions determined above. The test results are shown in Table 6.
[0189] The results showed that the differences in the ion ratios of the 25 PAHs were all less than ±30%, and the ion ratio test met the requirements.
[0190] 1.3 Linearity
[0191] Preparation of series of mixed reference solutions: Prepare 6 different concentrations of matrix mixed reference solutions, and the concentration range should be at least ±50% of the concentration of the target compound in the test sample. The concentrations of the series of mixed reference solutions Level 1 to Level 6 are shown in Table 4. Take the above series of matrix mixed reference solutions and analyze them according to the GC-MS / MS conditions determined above. The test results are detailed in Table 7.
[0192] The results showed that within the concentration range investigated, the correlation coefficient r was greater than 0.99, and the peak area ratios and concentration ratios of the 25 PAHs to the internal standard had good linearity.
[0193] Table 7 Detection limit, quantification limit, linear range, calibration curve and correlation coefficient of 25 PAHs
[0194]
[0195]
[0196] 1.4 Limit of detection and limit of quantification
[0197] The mixed reference substance stock solution was diluted step by step and analyzed and tested according to the GC-MS / MS conditions determined above. The test results are shown in Table 7.
[0198] Result analysis: The signal-to-noise ratio (S / N) of each substance at each concentration point was recorded. When S / N≈3, it was the limit of detection (LOD), and when S / N≈10, it was the limit of quantification (LOQ). The detection limit of 25 PAHs was between 0.098 and 4.980 ng / ml, and the quantification limit was between 0.103 and 9.960 ng / ml.
[0199] 1.5 Accuracy / Repeatability
[0200] According to the difference in the response of 25 PAHs on the instrument, different levels of spiking were performed. Nap, Acy, Ace, BcFL, IP, DBahA, BghiP, the spiking levels of 7 PAHs were 5μg / kg, 20μg / kg, and 100μg / kg. BaA, CPP, CHR, BbFA, BkFA, BjFA, BeP, BaP, MCH, DBalP, DBaeP, DBaiP, DBahP, the spiking levels of 13 PAHs were 10μg / kg, 40μg / kg, and 200μg / kg. Flu, Phe, Ant, the spiking levels of 3 were 60μg / kg, 120μg / kg, and 240μg / kg. Flt, Pyr, the spiking levels of 2 PAHs were 40μg / kg, 80μg / kg, and 160μg / kg. Each spiking level was repeated 3 times. The analysis and testing were carried out according to the above-mentioned determination method. The results are shown in Table 8.
[0201] Result analysis: The recoveries of 9 spiked test solutions were between 79.4% and 108.1%, and the RSD% was between 3.9% and 11.8%. The recoveries and RSD were within the acceptable range, and the accuracy and repeatability were good.
[0202]
[0203] 1.6 Stability
[0204] 1 μl of the mixed reference solution and matrix mixed reference solution of the same concentration were injected into the gas chromatography-tandem mass spectrometer at 0, 6, 12, 18, 24, and 48 h, respectively, and analyzed according to the above-mentioned determination method. The relative peak area RSD and RAD of each common peak at different time points were calculated. The results are shown in Table 9.
[0205] Result analysis: From Table 9, it can be seen that the relative peak area RAD value of each target compound within 48 hours is ≤20%, the relative chromatographic peak area RSD of the target compound at all time points is ≤20%, and the mixed reference solution and the matrix mixed reference solution are stable at room temperature for 48 hours.
[0206] Table 9 48h stability of mixed reference solution and licorice spiked sample solution
[0207]
[0208] 2. Methodological validation of PAHs detection and analysis methods in Atractylodes macrocephala
[0209] 2.1 Exclusivity
[0210] Blank matrix solution: Take a blank matrix sample of Atractylodes macrocephala, and prepare a blank matrix solution of Atractylodes macrocephala according to the blank matrix solution preparation method determined above.
[0211] The blank solution, blank solvent (dichloromethane), blank matrix solution, matrix mixed reference solution and mixed reference solution were analyzed and tested according to the GC-MS / MS conditions determined above. The test results are detailed in Table 10. The example chromatogram is shown in Figure 9-2 .
[0212] The results showed that: within the range of ±0.1min of the retention time of the target compound, there were no interfering peaks in the blank solvent (dichloromethane) and the blank solution, and there were detections at the retention time of the blank matrix solution, which could be confirmed as positive by the ion ratio. Since PAHs were detected to varying degrees in the Atractylodes samples, and since the verification results of the ion ratio and retention time were good, false positive results could be effectively avoided by examining the retention time and three ion channels during the actual detection of the samples. It can be considered that the specificity of PAHs meets the requirements.
[0213] Table 10 Specificity and ion ratio test results of the analysis method for detecting polycyclic aromatic hydrocarbons in Atractylodes macrocephala
[0214]
[0215] 2.2 Ion ratio
[0216] The mixed reference solution and the matrix mixed reference solution were respectively analyzed and tested according to the GC-MS / MS conditions determined above. The test results are shown in Table 10.
[0217] The results showed that the differences in the ion ratios of the 25 PAHs were all less than ±30%, and the ion ratio test met the requirements.
[0218] 1.3 Linearity
[0219] Preparation of series of mixed reference solutions: Prepare six different concentrations of matrix mixed reference solutions, the concentration range of which should be at least ±50% of the concentration of the target compound in the test sample. The concentrations of the series of mixed reference solutions Level 1 to Level 6 are shown in Table 5.
[0220] The above series of matrix mixed reference substance solutions were respectively taken for analysis and testing according to the GC-MS / MS conditions determined above. The test results are shown in Table 11.
[0221] The results showed that within the concentration range investigated, the correlation coefficient r was greater than 0.99, and the peak area ratios and concentration ratios of the 25 PAHs to the internal standard had good linearity.
[0222] Table 11 Detection limit, quantification limit, linear range, calibration curve and correlation coefficient of 25 PAHs
[0223]
[0224] 2.4 Limit of detection and limit of quantification
[0225] The operation is the same as the above “1.4 Detection limit and quantification limit”. The test results are shown in Table 11.
[0226] Result analysis: The signal-to-noise ratio (S / N) of each substance at each concentration point was recorded. When S / N≈3, it was the limit of detection (LOD), and when S / N≈10, it was the limit of quantification (LOQ). The detection limit of 25 PAHs was between 0.098 and 4.980 ng / ml, and the quantification limit was between 0.103 and 9.960 ng / ml.
[0227] 2.5 Accuracy / Repeatability
[0228] According to the response differences of 25 PAHs on the instrument, different levels of spiking were performed. Nap, Acy, Ace, BcFL, BaA, CPP, CHR, BbFA, BkFA, BjFA, BeP, BaP, IP, DBahA, BghiP, the spiking levels of 15 PAHs were 5μg / kg, 20μg / kg, and 100μg / kg. Flu, Phe, Ant, Flt, Pyr, MCH, DBalP, DBaeP, DBaiP, DBahP, the spiking levels of 10 PAHs were 10μg / kg, 40μg / kg, and 200μg / kg. Each spiking level was repeated 3 times. The analysis and testing were carried out according to the above-mentioned determination method. The results are shown in Table 12.
[0229] Result analysis: The recoveries of 9 spiked test solutions were between 86.4% and 110.7%, and the RSD% was between 3.5% and 14.2%. The recoveries and RSD were within the acceptable range, and the accuracy and repeatability were good.
[0230] 2.6 Stability
[0231] 1 μl of the mixed reference solution and matrix mixed reference solution of the same concentration were injected into the gas chromatography-tandem mass spectrometer at 0, 6, 12, 18, 24, and 48 h, and analyzed according to the above-mentioned determination method. The relative peak area RSD and RAD of each common peak at different time points were calculated. The results are shown in Table 13.
[0232] Result analysis: From Table 13, it can be seen that the relative peak area RAD value of each target compound within 48 hours is ≤20%, the relative chromatographic peak area RSD of the target compound at all time points is ≤20%, and the mixed reference solution and the matrix mixed reference solution are stable at room temperature for 48 hours.
[0233]
[0234] Table 13 48h stability of mixed reference solution and Atractylodes macrocephala spiked sample solution
[0235]
[0236] Beneficial Effects
[0237] Compared with the prior art, the present invention has the following advantages and effects:
[0238] 1. From the perspective of detection methods, this study established an analytical method suitable for the determination of 25 PAHs in medicinal materials. The types of target compounds detected include PAHs that are prioritized for control in the food and environmental fields by the US Environmental Protection Agency and the European Food Safety Authority. Through the investigation of instrument conditions and the optimization of sample pretreatment conditions, a GC-MS / MS method suitable for the detection of 25 PAHs in medicinal materials was established, and the accuracy and reliability of this method for quantitative analysis of target compounds were demonstrated through methodological verification. Compared with existing literature, this method can detect more PAHs in samples in one experiment, especially heavy PAHs with high carcinogenicity and toxicity that are of greater concern in the food field. The method has a wide detection range and can more comprehensively reflect the contamination of PAHs in medicinal materials, which is conducive to a comprehensive and rapid assessment of the contamination and safety risks of PAHs in Chinese medicinal materials.
[0239] 2. From the perspective of technological advancement, compared with the national standard GB5009.265-2021 "Determination of Polycyclic Aromatic Hydrocarbons in Food" and other existing detection methods that use pure solvents to prepare standard curve solutions, this method takes into account the influence of the complex matrix of medicinal materials on the target compounds, and uses a matrix matching method to prepare standard curve solutions to reduce matrix effect interference and make the test results more accurate. At the same time, a suitable analytical protective agent is added to the test solution to improve the chromatographic separation of the target compounds and the problem of chromatographic peak tailing, which is conducive to the accurate quantification of the target compounds. In addition, this method uses the multiple reaction monitoring scanning mode (MRM) of gas chromatography-tandem mass spectrometry for quantitative analysis. Compared with the selected ion monitoring scanning mode (SIM) used in the national standard GB5009.265-2021 "Determination of Polycyclic Aromatic Hydrocarbons in Food" detection method, this method can reduce the baseline noise of medicinal samples with high matrix background and eliminate more interference, thereby improving detection sensitivity and accuracy. The elution peaks of 25 PAHs were stable and well separated, with recoveries ranging from 73.3% to 114%. The detection limits of 25 PAHs were between 0.098 and 4.980 ng / ml, and the quantification limits were between 0.103 and 9.960 ng / ml. This method has the advantages of low detection limit and accurate quantification, and is suitable for trace analysis of PAHs in complex medicinal materials matrices.
[0240] 3. From the perspective of convenience and safety of experimental operation, this method simplifies the sample pretreatment steps. Compared with the existing technology, this method is based on the different matrix characteristics of medicinal materials and foods, and discards the strong polar solvent extraction, saponification degreasing and Florisil column purification steps. It directly uses n-hexane as the extraction solvent, concentrates the extract and purifies the sample through a molecular imprinting column, making the experimental operation more time-saving and simple. In addition, only two organic reagents, n-hexane and dichloromethane, are used in the sample processing process, and anhydrous ethanol, potassium hydroxide-ethanol solution, ethyl acetate, acetone, isooctane and other organic reagents used in other detection methods are not involved, which improves the safety of experimental operation while reducing environmental pollution. BRIEF DESCRIPTION OF THE DRAWINGS
[0241] Figure 1 Comparative chromatograms of BbFA, BjFA, and BkFA of different chromatographic columns, (a) is a DB-5MS column, and (b) is a DB-EUPAH column.
[0242] Figure 2 Comparative chromatograms of IP and DBahA before and after adjusting the temperature program, (a) is before adjusting the temperature program, and (b) is after adjusting the temperature program.
[0243] Figure 3 This is a comparison chart of the chromatographic peak areas of substances under different injection methods and split ratios.
[0244] Figure 4-1Comparison of the improvement of chromatographic peak tailing of DBalP, DBaeP, DBaiP and DBahP by different analytical protective agents, (a) is without analytical protective agent, (b) is with ribonucleolactone, (c) is with polyethylene glycol-triethylene glycol; Figure 4-2 The effect of different analytical protective agent volumes on the peak area of the target compound.
[0245] Figure 5 Comparison of chromatographic peaks of Nap-D8, Nap, Acy, AcP-d10, and Ace in spiked samples under SIM and MRM scanning modes, (a) is SIM mode; (b) is MRM mode.
[0246] Figure 6 Total ion current chromatogram of GC-MS determination of 25 PAH standard solutions and 5 internal standard solutions (50.0 μg / L).
[0247] Figure 7-1 is the recovery rate of the target compound under different types of extraction solvents; Figure 7-2 is the recovery rate of the target compound under different types of extraction solvents; Figure 7-3 is the recovery rate of the target compound under different extraction solvent volumes; Figure 7-4 is the recovery rate of the target compound under different extraction times.
[0248] Figure 8-1 is the recovery rate of the target compound under different solid phase extraction columns; Figure 8-2 is the recovery rate of the target compound under different elution solvent volumes; Figure 8-3 is the recovery rate of the target compound under different elution solvent types; Figure 8-4 is the recovery rate of the target compound under different elution solvent volumes.
[0249] Figure 9-1 This is the chromatogram of the specificity test of the analytical method for detecting polycyclic aromatic hydrocarbons in licorice, from top to bottom, they are the matrix mixed reference solution, mixed reference solution, and blank solution; Figure 9-2 This is the chromatogram of the specificity test of the analytical method for detecting polycyclic aromatic hydrocarbons in Atractylodes macrocephala. From top to bottom, they are the matrix mixed reference solution, mixed reference solution, and blank solution.
[0250] Figure 10-1 The chromatograms of licorice sample s2, (a) is the complete chromatogram, (b) is the enlarged chromatogram from 6 to 20 min, and (c) is the enlarged chromatogram from 20 to 43 min; Figure 10-2 These are the chromatograms of Atractylodes macrocephala sample S9, (a) is the complete chromatogram, (b) is the enlarged chromatogram from 6 to 20 min, and (c) is the enlarged chromatogram from 20 to 43 min. DETAILED DESCRIPTION
[0251] The present invention is described in detail below by specifically implementing this method to detect the residual amount of polycyclic aromatic hydrocarbons in medicinal materials.
[0252] Example 1
[0253] Determination of polycyclic aromatic hydrocarbons residues in liquorice
[0254] 1. Preparation of blank solution, blank matrix solution and analytical protective agent solution
[0255] Preparation of blank solution: Accurately measure 40 ml of n-hexane and place it in a rotary evaporator. Concentrate under reduced pressure in a 35°C water bath until about 2 ml of solvent remains, transfer to an Anpu MIP-PAHs purification column (1g / 10 ml, pre-washed with 5 ml of dichloromethane and 5 ml of n-hexane), wash the residue once with 3 ml of n-hexane, transfer the washing liquid to the same Anpu MIP-PAHs purification column, rinse twice with n-hexane, 3 ml each time, and then elute with 15 ml of dichloromethane, collect all the eluate, place it in a 35°C water bath and concentrate under reduced pressure until about 1 ml of solvent remains, add dichloromethane to make up to 2 ml, vortex to mix, and pass through a 0.22μm organic filter membrane to obtain.
[0256] Preparation of blank matrix solution: Take licorice blank matrix sample, crush it into powder (pass through No. 4 sieve), take about 1g, accurately weigh, put it in a 50mL stoppered centrifuge tube, add 40ml of n-hexane, and ultrasonically extract 3 times, 20ml for the first time, 10ml for the second and third times respectively, ultrasonicate for 30min each time, and centrifuge (3500r / min) for 5min. The supernatants were combined, concentrated under reduced pressure in a 35°C water bath until about 2 ml of solvent remained, and transferred to an Anpu MIP-PAHs purification column (1 g / 10 ml, pre-washed with 5 ml of dichloromethane and 5 ml of n-hexane). The residue was washed once with 3 ml of n-hexane, and the washing liquid was transferred to the same Anpu MIP-PAHs purification column, and then rinsed twice with n-hexane, 3 ml each time, and then eluted with 15 ml of dichloromethane. All the eluates were collected, concentrated under reduced pressure in a 35°C water bath until about 1 ml of solvent remained, and dichloromethane was added to make up to 2 ml. The mixture was vortexed to mix well, and passed through a 0.22 μm organic filter membrane to obtain the product.
[0257] Preparation of analytical protective agent solution: Accurately measure 100 μl of polyethylene glycol and 200 μl of triethylene glycol, place in a 10 ml volumetric flask, dilute to the scale with acetone, shake well, and store in a -18°C refrigerator.
[0258] 2. Preparation of reference solution
[0259] Preparation of reference stock solutions: Take appropriate amounts of 25 PAHs reference substances, accurately weigh them, and add n-hexane to prepare reference stock solutions. The specific concentration C1 is shown in Table 3.
[0260] Preparation of mixed reference substance stock solution: Accurately measure an appropriate amount of the above reference substance stock solution and dilute it with n-hexane to form a mixed reference substance stock solution. The specific concentration C2 is shown in Table 3.
[0261] Preparation of mixed reference solution: Accurately measure an appropriate amount of mixed reference stock solution and add n-hexane to prepare a mixed reference solution. The specific concentration C4 is shown in Table 3.
[0262] Preparation of internal standard mixed reference solution: Accurately measure 1 ml of 5 kinds of polycyclic aromatic hydrocarbon deuterated mixed reference (1000 μg / ml), place it in a 100 ml volumetric flask, add n-hexane to dilute it into 10 μg / ml internal standard mixed reference solution, shake well, and obtain.
[0263] Accurately pipette acetonitrile to 100ml, shake well. Accurately pipette 1ml from 100ml, dilute to 10ml with dichloromethane, shake well, and use this as the internal standard working solution. Shake well to obtain.
[0264] Preparation of matrix mixed reference solution: Accurately measure an appropriate amount of mixed reference stock solution and add blank matrix solution to prepare a series of matrix mixed reference solutions. The specific concentrations are shown in Table 4.
[0265] 3. Preparation of test solution
[0266] Take licorice root, crush it into powder (pass through No. 4 sieve), take about 2g, weigh it accurately, put it in a 50mL stoppered centrifuge tube, add 40ml of n-hexane, and ultrasonically extract it 3 times, 20ml for the first time, 10ml for the second and third times respectively, ultrasonicate for 30min each time, and centrifuge (3500r / min) for 5min. The supernatants were combined, concentrated under reduced pressure in a 35°C water bath until about 2 ml of solvent remained, and transferred to an Anpu MIP-PAHs purification column (1 g / 10 ml, pre-washed with 5 ml of dichloromethane and 5 ml of n-hexane). The residue was washed once with 3 ml of n-hexane, and the washing liquid was transferred to the same Anpu MIP-PAHs purification column, and then rinsed twice with n-hexane, 3 ml each time, and then eluted with 15 ml of dichloromethane. All the eluates were collected, concentrated under reduced pressure in a 35°C water bath until about 1 ml of solvent remained, and dichloromethane was added to make up to 2 ml. The mixture was vortexed to mix well, and passed through a 0.22 μm organic filter membrane to obtain the product.
[0267] 4. Gas chromatography-mass spectrometry conditions
[0268] Agilent DB-EUPAH (20m×0.18mm×0.14μm) chromatographic column. Carrier gas is high-purity helium (purity>99%). Inlet temperature 300℃. Splitless injection. Column flow rate 1.0mL / min. Injection volume 1μl. Heating program: initial 80℃, hold for 2 minutes, increase to 250℃ at 10℃ per minute, hold for 2 minutes, then increase to 290℃ at 8℃ per minute, hold for 8 minutes, then increase to 320℃ at 20℃ per minute, hold for 16 minutes. Ion source temperature 230℃. Interface temperature 280℃. EI ionization mode. See Table 1 for the monitoring ion pairs and collision energies of 25 PAHs and internal standard references.
[0269] 5. Determination method
[0270] The analysis was performed according to the determination method determined by the present invention.
[0271] 6. The test results are shown in Table 14. The sample chromatogram is shown in Figure 10-1 .
[0272]
[0273] Example 2
[0274] Determination of polycyclic aromatic hydrocarbons residues in Atractylodes macrocephala
[0275] 1. Preparation of blank solution, blank matrix solution and analytical protective agent solution
[0276] Preparation of blank solution: same as in Example 1.
[0277] Preparation of blank matrix solution: Take a blank matrix sample of Atractylodes macrocephala, crush it into powder (pass through a No. 4 sieve), take about 1g, accurately weigh, place in a 50mL stoppered centrifuge tube, add 40ml of n-hexane, and ultrasonically extract 3 times, 20ml for the first time, 10ml for the second and third times respectively, ultrasonically extract for 30min each time, and centrifuge (3500r / min) for 5min. The supernatants were combined, concentrated under reduced pressure in a 35°C water bath until about 2 ml of solvent remained, and transferred to an Anpu MIP-PAHs purification column (1 g / 10 ml, pre-washed with 5 ml of dichloromethane and 5 ml of n-hexane). The residue was washed once with 3 ml of n-hexane, and the washing liquid was transferred to the same Anpu MIP-PAHs purification column, and then rinsed twice with n-hexane, 3 ml each time, and then eluted with 15 ml of dichloromethane. All the eluates were collected, concentrated under reduced pressure in a 35°C water bath until about 1 ml of solvent remained, and dichloromethane was added to make up to 2 ml. The mixture was vortexed to mix well, and passed through a 0.22 μm organic filter membrane to obtain the product.
[0278] Preparation of analytical protective agent solution: same as in Example 1.
[0279] 2. Preparation of reference solution
[0280] Preparation of reference substance stock solution: same as in Example 1.
[0281] Preparation of mixed reference substance stock solution: Accurately measure an appropriate amount of the above reference substance stock solution and dilute it with n-hexane to form a mixed reference substance stock solution. The specific concentration C3 is shown in Table 3.
[0282] Preparation of internal standard mixed reference solution: same as in Example 1.
[0283] Preparation of mixed reference solution: Accurately measure an appropriate amount of mixed reference stock solution and add n-hexane to prepare a mixed reference solution. The specific concentration C5 is shown in Table 3.
[0284] Preparation of matrix mixed reference solution: Accurately measure an appropriate amount of the mixed reference stock solution and add blank matrix solution to prepare a series of matrix mixed reference solutions. The specific concentrations are shown in Table 5.
[0285] 3. Preparation of test solution
[0286] Take the Atractylodes macrocephala, crush it into powder (pass through a No. 4 sieve), take about 2g, weigh it accurately, put it in a 50mL stoppered centrifuge tube, add 40ml of n-hexane, and ultrasonically extract it 3 times, 20ml for the first time, 10ml for the second and third times respectively, ultrasonicate for 30min each time, and centrifuge (3500r / min) for 5min. The supernatants were combined, concentrated under reduced pressure in a 35°C water bath until about 2 ml of solvent remained, and transferred to an Anpu MIP-PAHs purification column (1 g / 10 ml, pre-washed with 5 ml of dichloromethane and 5 ml of n-hexane). The residue was washed once with 3 ml of n-hexane, and the washing liquid was transferred to the same Anpu MIP-PAHs purification column, and then rinsed twice with n-hexane, 3 ml each time, and then eluted with 15 ml of dichloromethane. All the eluates were collected, concentrated under reduced pressure in a 35°C water bath until about 1 ml of solvent remained, and dichloromethane was added to make up to 2 ml. The mixture was vortexed to mix well, and passed through a 0.22 μm organic filter membrane to obtain the product.
[0287] 4. Gas chromatography-mass spectrometry conditions
[0288] Same as Example 1.
[0289] 5. Determination method
[0290] Same as Example 1.
[0291] 6. The test results are shown in Table 15. The sample chromatogram is shown in Figure 10-2 .
[0292]
Claims
1. A method for detecting the residual amount of polycyclic aromatic hydrocarbons in traditional Chinese medicines, using gas chromatography-mass spectrometry, the method comprising the following steps: 1) Preparation of test solution: Take Chinese medicinal materials and treat them with solvent to obtain test solution; 2) Preparation of reference solution: Take 25 PAH standards and dissolve them in solvent to obtain reference solution; 3) Determination: inject the test solution and the reference solution into a gas chromatography-mass spectrometry instrument to obtain a chromatogram, and calculate the content of 25 PAHs in the test solution based on the chromatogram; Wherein, the chromatographic conditions of the gas chromatography-mass spectrometry chromatograph are: Agilent DB-EUPAH (20 m × 0.18 mm × 0.14 μm) chromatographic column was used; The carrier gas is high-purity helium; Inlet temperature 250-350℃; Column flow rate 0.5-1.5mL / min; Injection volume 1-5 μl; Heating program: initially 75-85°C, hold for 1-3 minutes, increase the temperature by 5-10°C per minute to 240-260°C, hold for 1-3 minutes, then increase the temperature by 5-10°C per minute to 280-300°C, hold for 5-10 minutes, then increase the temperature by 15-25°C per minute to 310-350°C, hold for 15-20 minutes; Mass spectrometry conditions: Detected by triple quadrupole tandem mass spectrometer; ion source was electron impact (EI) ion source, ion source temperature was 220-240°C, collision gas was argon, flow rate was 0.5-1.5 mL / min, mass spectrometry transmission interface temperature was 270-290°C.
2. The detection method according to claim 1, characterized in that: According to needs, it can also include the preparation of blank solution, blank matrix solution, analytical protectant solution, internal standard mixed reference solution and matrix mixed reference solution. After these solutions are injected into the gas chromatography-mass spectrometry chromatograph as blanks and controls, they are beneficial to the correction of the chromatogram, improve the detection accuracy, and facilitate the accuracy of the calculation results.
3. The detection method according to claim 1, characterized in that: The detection method comprises the following steps: 1) Preparation of test solution: Take 1-3g of the Chinese medicinal material, place it in a 40-60mL stoppered centrifuge tube, add 20-40ml of n-hexane, dichloromethane or a mixture thereof as a solvent, perform ultrasonic extraction 1-3 times, each ultrasonication for 10-30min, concentrate the obtained supernatant under reduced pressure in a 30-40°C water bath until 1-3ml of solvent remains, transfer it to a solid phase extraction column, rinse it with 3-9ml of n-hexane 1-3 times, and then elute it with 5-15ml of any one of dichloromethane, ethyl acetate or cyclohexane, collect the eluate, place it in a 30-40°C water bath and concentrate it under reduced pressure until 0.5-1.5ml of solvent remains, and make the volume to 2-3ml; 2) Preparation of reference solution: Preparation of reference solution: Take 25 PAH reference substances separately or mix them and add n-hexane to prepare reference solution; 3) Determination method Take 1-5 μl of the reference solution and the test solution and inject them into the gas chromatography-tandem mass spectrometer for determination. The content of 25 kinds of PAHs in the test solution is calculated by the internal standard calibration curve method. Wherein, the chromatographic conditions of the gas chromatography-mass spectrometry chromatograph are: Agilent DB-EUPAH (20 m × 0.18 mm × 0.14 μm) chromatographic column was used; The carrier gas is high-purity helium; Inlet temperature 250-350℃; splitless injection; Column flow rate 0.5-1.5mL / min; Injection volume 1-5 μl; Heating program: initially 75-85°C, hold for 1-3 minutes, increase the temperature by 5-10°C per minute to 240-260°C, hold for 1-3 minutes, then increase the temperature by 5-10°C per minute to 280-300°C, hold for 5-10 minutes, then increase the temperature by 15-25°C per minute to 310-350°C, hold for 15-20 minutes; Mass spectrometry conditions: Detected by triple quadrupole tandem mass spectrometer; ion source was electron impact (EI) ion source, ion source temperature was 220-240°C, collision gas was argon, flow rate was 0.5-1.5 mL / min, mass spectrometry transmission interface temperature was 270-290°C.
4. The detection method according to claim 3, characterized in that: If necessary, a blank solution can also be used, and its preparation method is as follows: take n-hexane and concentrate it, then transfer it to the Anpu MIP-PAHs purification column, elute it with n-hexane, and then elute it with dichloromethane, collect all the eluents, concentrate them, and add dichloromethane to make up the volume; if necessary, a blank matrix solution can also be used, and its preparation method is as follows: take 1-3g of the blank matrix sample, put it in a 40-60mL stoppered centrifuge tube, add 20-40ml of n-hexane, dichloromethane or a mixture thereof as a solvent, and ultrasonically extract it 1-3 times, each ultrasonication for 10-30min, to obtain The supernatant is concentrated under reduced pressure in a 30-40°C water bath until 1-3 ml of solvent remains, transferred to a solid phase extraction column, rinsed 1-3 times with 3-9 ml of n-hexane, and then eluted with 5-15 ml of any one of dichloromethane, ethyl acetate or cyclohexane. The eluate is collected and concentrated under reduced pressure in a 30-40°C water bath until 0.5-1.5 ml of solvent remains, and the volume is fixed to 2-3 ml. If necessary, an analytical protective agent solution can also be used, and its preparation method is as follows: a ribonucleic acid lactone or a polyethylene glycol-triethylene glycol mixture is added to a solvent to prepare an analytical protective solution.
5. The detection method according to claim 3, characterized in that: If necessary, an internal standard mixed reference solution can also be used; its preparation method is as follows: take 0.5-2 ml of 5 kinds of polycyclic aromatic hydrocarbon deuterated mixed reference, place it in a 50-150 ml volumetric flask, add n-hexane to dilute it into 5-15 μg / ml internal standard mixed reference solution, shake well, and obtain; if necessary, a matrix mixed reference solution can also be used, and its preparation method is as follows: measure an appropriate amount of mixed reference stock solution, add blank matrix solution to prepare a series of matrix mixed reference solutions.
6. The detection method according to claim 3, characterized in that: The detection method comprises the following steps: 1) Preparation of test solution: Take Chinese herbal medicine, crush it into powder, take about 2g, weigh it accurately, put it in a 50mL stoppered centrifuge tube, add n-hexane, ultrasonically extract 3 times, 20ml for the first time, 10ml for the second and third times, ultrasonic for 30min each time, centrifuge at 3500r / min for 5min, combine the supernatants, concentrate under reduced pressure in a 35℃ water bath until the solvent remains about 2ml, transfer to the Anpu MIP-PAHs purification column, wash the concentration bottle with 3ml of n-hexane once, transfer the washing liquid to the same Anpu MIP-PAHs purification column, rinse with n-hexane twice, 3ml each time, elute with 15ml of dichloromethane, collect all the eluents, place it in a 35℃ water bath and concentrate under reduced pressure until the solvent remains about 1ml, add dichloromethane to make up to 2ml, vortex to mix, pass through a 0.22μm organic filter membrane, and obtain. 2) Preparation of blank solution, blank matrix solution and analytical protective agent solution: Preparation of blank solution: 40 ml of n-hexane was placed in a rotary evaporator, and concentrated under reduced pressure on a 35°C water bath until about 2 ml of solvent remained, and then transferred to the Anpu MIP-PAHs purification column. The concentration bottle was washed once with 3 ml of n-hexane, and the washing liquid was also transferred to the same Anpu MIP-PAHs purification column, rinsed twice with n-hexane, 3 ml each time, and eluted with 15 ml of dichloromethane. All the eluents were collected, and concentrated under reduced pressure on a 35°C water bath until about 1 ml of solvent remained, and dichloromethane was added to make up to 2 ml, vortexed to mix, and filtered through a 0.22 μm organic filter membrane to obtain. Preparation of blank matrix solution: Take the blank matrix sample, crush it into powder (pass through No. 4 sieve), take about 1g, accurately weigh, put it in a 50mL stoppered centrifuge tube, add 40ml of n-hexane, ultrasonically extract 3 times, 20ml for the first time, 10ml for the second and third times, ultrasonically extract for 30min each time, centrifuge (3500r / min) for 5min, combine the supernatants, concentrate under reduced pressure in a 35℃ water bath until the solvent remains about 2ml, and transfer to the Anpu MIP-PAHs purification system. The residue was washed once with 3 ml of n-hexane, and the washing liquid was transferred to the same Anpu MIP-PAHs purification column, and then washed twice with n-hexane, 3 ml each time, and then eluted with 15 ml of dichloromethane. All the eluents were collected, placed in a 35°C water bath and concentrated under reduced pressure until the solvent remained about 1 ml, and dichloromethane was added to make up to 2 ml, vortexed to mix, and filtered through a 0.22 μm organic filter membrane to obtain. The analytical protective agent solution uses an acetone solution containing 1% polyethylene glycol and 2% triethylene glycol as the analytical protective agent solution; the preparation method is as follows: accurately measure 100 μl polyethylene glycol and 200 μl triethylene glycol, place them in a 10 ml volumetric flask, dilute to the scale with acetone, shake well, and obtain the analytical protective agent solution, which is stored in a -18°C refrigerator. 3) Preparation of reference solution: Preparation of reference stock solution: Take appropriate amount of 25 PAHs reference substances, weigh accurately, add n-hexane to make reference stock solution, and store in -18℃ refrigerator. Preparation of mixed reference substance stock solution: Take an appropriate amount of the above reference substance stock solution, dilute it with n-hexane to make a mixed reference substance stock solution, and store it in a -18℃ refrigerator. Preparation of mixed reference solution: Take an appropriate amount of mixed reference stock solution, add n-hexane to prepare mixed reference solution. Preparation of internal standard mixed reference solution: Take 1 ml of 5 kinds of deuterated mixed reference of polycyclic aromatic hydrocarbons (1000 μg / ml), put it in a 100 ml volumetric flask, add n-hexane to dilute it into 10 μg / ml internal standard mixed reference solution, shake well, and obtain. Preparation of matrix mixed reference solution: Take an appropriate amount of mixed reference stock solution and add blank matrix solution to prepare a series of matrix mixed reference solutions; 4) Determination method Take 1 ml of blank solution, blank solvent (dichloromethane), blank matrix solution, matrix mixed reference solution, mixed reference solution and test solution respectively, add 20-50 μl of analytical protective agent solution and 50 μl of internal standard mixed reference solution, mix well, take 1 μl of the above solutions respectively and inject them into gas chromatography tandem mass spectrometer for determination, calculate the content of 25 kinds of PAHs in the test solution by internal standard calibration curve method, Chromatographic conditions: Agilent DB-EUPAH (20m×0.18mm×0.14μm) chromatographic column, carrier gas is high-purity helium (purity>99%), injection port temperature is 300°C, non-split injection, column flow rate is 1.0mL / min, injection volume is 1μl, heating program: initial 80°C, hold for 2 minutes, increase to 250°C at 10°C per minute, hold for 2 minutes, then increase to 290°C at 8°C per minute, hold for 8 minutes, then increase to 320°C at 20°C per minute, hold for 16 minutes; Mass spectrometry conditions: Detected by triple quadrupole tandem mass spectrometer; ion source was electron impact (EI) ion source, ion source temperature was 230°C, collision gas was argon, flow rate was 1.0 mL / min, and mass spectrometry transmission interface temperature was 280°C.
7. The detection method according to claim 6, characterized in that: The five internal standard compounds are five deuterated polycyclic aromatic hydrocarbon compounds, namely naphthalene-D8, acenaphthene-D10, phenanthrene-D10, chrysene-D12, and perylene-D12.
8. The detection method according to claim 6, characterized in that: The Chinese medicinal materials are selected from any kind of Chinese medicinal materials.
9. The detection method according to claim 6, characterized in that: The Chinese medicinal material is liquorice or atractylodes macrocephala.
Citation Information
Patent Citations
Method for detecting polycyclic aromatic hydrocarbon residue in plant traditional Chinese medicinal materials and extracts
CN111562334A
Cited By
Method for identifying traditional Chinese medicine evodia rutaecarpa base based on GC-IMS characteristic odor substances
CN120064519A
